scholarly journals Infrared thermography for monitoring severity and treatment of diabetic foot infections

2020 ◽  
Vol 2 (1) ◽  
pp. 1-10
Author(s):  
Kor H Hutting ◽  
Wouter B aan de Stegge ◽  
Rombout R Kruse ◽  
Jeff G van Baal ◽  
Sicco A Bus ◽  
...  

Monitoring of diabetic foot infections is largely based on clinical assessment, which is limited by moderate reliability. We conducted a prospective study to explore monitoring of thermal asymmetry (difference between mean plantar temperature of the affected and unaffected foot) for the assessment of severity of diabetic foot infections. In patients with moderate or severe diabetic foot infections (International Working Group on the Diabetic Foot infection-grades 3 or 4) we measured thermal asymmetry with an advanced infrared thermography setup during the first 4–5 days of in-hospital treatment, in addition to clinical assessments and tests of serum inflammatory markers (white blood cell counts and C-reactive protein levels). We assessed the change in thermal asymmetry from baseline to final assessment, and investigated its association with infection-grades and serum inflammatory markers. In seven included patients, thermal asymmetry decreased from median 1.8°C (range: −0.6 to 8.4) at baseline to 1.5°C (range: −0.1 to 5.1) at final assessment (P = 0.515). In three patients who improved to infection-grade 2, thermal asymmetry at baseline (median 1.6°C (range: −0.6 to 1.6)) and final assessment (1.5°C (range: 0.4 to 5.1)) remained similar (P = 0.302). In four patients who did not improve to infection-grade 2, thermal asymmetry decreased from median 4.3°C (range: 1.8 to 8.4) to 1.9°C (range: −0.1 to 4.4; P = 0.221). No correlations were found between thermal asymmetry and infection-grades (r = −0.347; P = 0.445), CRP-levels (r = 0.321; P = 0.482) or WBC (r = −0.250; P = 0.589) during the first 4–5 days of hospitalization. Based on these explorative findings we suggest that infrared thermography is of no value for monitoring diabetic foot infections during in-hospital treatment.

2011 ◽  
Vol 101 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Baris Akinci ◽  
Serkan Yener ◽  
Sena Yesil ◽  
Nur Yapar ◽  
Yasin Kucukyavas ◽  
...  

Background: Prediction of amputation would aid clinicians in the management of diabetic foot infections. We aimed to assess the predictive value of baseline and post-treatment levels of acute phase reactants in the outcome of patients with diabetic foot infections. Methods: We collected data prospectively during minimum follow-up of 6 months in patients with infected diabetic foot ulcers hospitalized in Dokuz Eylul University Hospital between January 1, 2003, and January 1, 2008. After excluding patients who did not attend the hospital for follow-up visits regularly (n = 36), we analyzed data from 165 foot ulcer episodes. Results: Limb ischemia and osteomyelitis were much more frequent in patients who underwent amputation. Wagner grade, which assesses ulcer depth and the presence of osteomyelitis or gangrene, was higher in patients who needed amputation. Ulcer size was slightly larger in the amputation group. Baseline and post-treatment C-reactive protein levels, erythrocyte sedimentation rates, white blood cell counts, and platelet counts were significantly elevated in patients who underwent amputation. Albumin levels were significantly suppressed in the amputation group. Univariate analysis showed that a 1-SD increase in baseline and post-treatment C-reactive protein levels, erythrocyte sedimentation rates, and white blood cell counts and a 1-SD decrease in post-treatment albumin levels were significantly associated with increased risk of amputation. Post-treatment C-reactive protein level was strongly associated with amputation risk. Conclusions: Circulating levels of acute phase reactants were associated with amputation risk in diabetic foot infections. (J Am Podiatr Med Assoc 101(1): 1–6, 2011)


2021 ◽  
Author(s):  
Javier Aragón‐Sánchez ◽  
Gerardo Víquez‐Molina ◽  
María Eugenia López‐Valverde ◽  
Javier Aragón‐Hernández ◽  
José María Rojas‐Bonilla ◽  
...  

2018 ◽  
Vol 8 (2-3) ◽  
pp. 32-36 ◽  
Author(s):  
Bikha Ram Devrajani ◽  
Samar Raza ◽  
Rubina Khushik ◽  
Syed Zulfiquar Ali Shah ◽  
Sanam Mari ◽  
...  

Diabetes Care ◽  
2013 ◽  
Vol 36 (7) ◽  
pp. 2054-2061 ◽  
Author(s):  
M. Du ◽  
A. Basu ◽  
D. Fu ◽  
M. Wu ◽  
M. Centola ◽  
...  

Blood ◽  
2010 ◽  
Vol 116 (22) ◽  
pp. 4631-4638 ◽  
Author(s):  
Rika Kanezaki ◽  
Tsutomu Toki ◽  
Kiminori Terui ◽  
Gang Xu ◽  
RuNan Wang ◽  
...  

Abstract Twenty percent to 30% of transient abnormal myelopoiesis (TAM) observed in newborns with Down syndrome (DS) develop myeloid leukemia of DS (ML-DS). Most cases of TAM carry somatic GATA1 mutations resulting in the exclusive expression of a truncated protein (GATA1s). However, there are no reports on the expression levels of GATA1s in TAM blasts, and the risk factors for the progression to ML-DS are unidentified. To test whether the spectrum of transcripts derived from the mutant GATA1 genes affects the expression levels, we classified the mutations according to the types of transcripts, and investigated the modalities of expression by in vitro transfection experiments using GATA1 expression constructs harboring mutations. We show here that the mutations affected the amount of mutant protein. Based on our estimates of GATA1s protein expression, the mutations were classified into GATA1s high and low groups. Phenotypic analyses of 66 TAM patients with GATA1 mutations revealed that GATA1s low mutations were significantly associated with a risk of progression to ML-DS (P < .001) and lower white blood cell counts (P = .004). Our study indicates that quantitative differences in mutant protein levels have significant effects on the phenotype of TAM and warrants further investigation in a prospective study.


2017 ◽  
Vol 31 (2) ◽  
pp. 407-412 ◽  
Author(s):  
Ashu Rastogi ◽  
Suja Sukumar ◽  
Abhishek Hajela ◽  
Soham Mukherjee ◽  
Pinaki Dutta ◽  
...  

2019 ◽  
Vol 23 (1) ◽  
pp. 122
Author(s):  
AdlyneR Asirvatham ◽  
Usha Menon ◽  
PraveenV Pavithran ◽  
JayakumarR Vasukutty ◽  
Harish Kumar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document